GenDx Strengthens Its Commitment to Better Healthcare in Indonesia
updated time:2026-09-04
updated time:2026-09-04
GenDx Strengthens Its Commitment to Better Healthcare in Indonesia
GenDx is pleased to announce an important milestone in its international expansion — the successful authorization of its Medical Device Import & Sales License in Indonesia.

This achievement represents an important step in GenDx’s commitment to expanding access to innovative, reliable, and accessible molecular diagnostic solutions across Southeast Asia.
As healthcare systems increasingly recognize the value of rapid and decentralized molecular testing, GenDx is working to make advanced molecular diagnostics more accessible beyond traditional centralized laboratories. Through its GENEYE® molecular POCT platform and rapid molecular diagnostic solutions, GenDx aims to support healthcare professionals with dependable testing technologies designed for use closer to patients.
Bringing Rapid Molecular Diagnostics Closer to Patients
Traditional molecular testing can often depend on centralized laboratories, specialized infrastructure, and longer turnaround times. GenDx’s approach is focused on helping address these challenges through point-of-care molecular diagnostics that combine simplicity, speed, and reliable detection.
Our solutions are built around three core principles:
🔬 Easy — Designed to simplify molecular testing and support decentralized diagnostic settings.
⚡ Rapid — Delivering fast results to help healthcare professionals make timely clinical decisions.
🎯 Accurate — Providing reliable molecular detection to support confident diagnostic decision-making.
With these capabilities, GenDx is positioned to support a broad range of infectious disease testing needs, including women’s health, respiratory infections, tuberculosis, and other infectious diseases.
A New Step Forward in Indonesia
Indonesia represents an important and dynamic healthcare market, with a growing need for accessible and efficient diagnostic technologies. The authorization of the Medical Device Import & Sales License provides an important foundation for GenDx and its local partners to introduce and support its molecular diagnostic solutions in the country.
Working together with local partners and healthcare stakeholders, GenDx looks forward to strengthening its presence in Indonesia and contributing to the development of more accessible diagnostic pathways.
Our goal is not simply to introduce another diagnostic technology. It is to help bring molecular testing closer to where healthcare decisions are made — closer to healthcare professionals, closer to communities, and ultimately closer to patients.
Looking Ahead
The Indonesia authorization marks another step in GenDx’s broader international expansion and reflects our continued commitment to making molecular diagnostics Easy, Rapid, and Accurate.
As we expand our global footprint, we remain focused on building strong local partnerships and delivering diagnostic solutions that can make a meaningful difference in healthcare.
GenDx — Infection POCT Innovator
Innovation for a Healthier Indonesia ID